Beam Therapeutics BEAM Ratios (2019-2026)

NASDAQ BEAM
$29.64 +0.18 (+0.61%)
As of: Sep 4, 2026 · 3:59 PM EDT
Reported Financials

Beam Therapeutics Quarterly Ratios

Periods 29 quarters
Latest Jun 2026

Beam Therapeutics reported a net margin of -25,036.33% for the quarter ended Jun 2026. These financial ratios cover 29 quarters of results from Jun 2019 through Jun 2026, standardized by Business Quant from the company’s SEC filings.

Ratios Jun2019 Sep2019 Dec2019 Mar2020 Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026 Jun2026
Profitability
EBT Margin
-3,685.19%-126.71%-896.36%-479.86%-516.90%-186.40%-367.51%-411.49%-558.88%45.59%-1,245.38%-773.12%-677.47%-300.51%-1,464.82%-1,208.26%-1,162.38%214.09%-306.72%-24,299.18%
EBIT Margin
-9,126.34%-124.31%-904.00%-492.23%-577.90%-444.10%-408.66%-507.79%-629.72%42.02%-1,405.29%-891.06%-746.40%-332.71%-1,596.87%-1,419.22%-1,307.60%-15.29%-337.81%-25,827.14%
EBITDA Margin
-9,126.34%-124.31%-904.00%-492.23%-577.90%-444.10%-408.66%-507.79%-629.72%42.02%-1,405.29%-891.06%-746.40%-332.71%-1,596.87%-1,419.22%-1,307.60%-15.29%-337.81%-25,827.14%
Operating Margin
-9,126.34%-124.31%-904.00%-492.23%-577.90%-444.10%-408.66%-507.79%-629.72%42.02%-1,405.29%-891.06%-746.40%-332.71%-1,596.87%-1,419.22%-1,307.60%-15.29%-337.81%-25,827.14%
Net Margin
-3,685.19%-126.71%-820.85%-432.08%-693.56%-191.39%-398.46%-411.49%-558.88%45.16%-1,331.57%-773.45%-677.47%-300.51%-1,450.20%-1,206.45%-1,162.38%214.09%-297.18%-25,036.33%
FCF Margin
-363.43%-22.59%2,409.68%-395.59%-546.13%-386.54%-497.73%-478.17%-568.44%41.58%-1,379.01%-721.80%-628.65%-263.86%-1,431.71%-940.07%-891.83%-76.26%-411.95%-13,981.63%
Efficiency
Assets AverageAssets Avg.
1,024.82M1,315.50M1,463.93M1,435.89M1,384.31M1,345.98M1,337.03M1,343.12M1,322.21M1,375.12M1,409.76M1,310.53M1,216.32M1,137.60M1,285.37M1,429.04M1,351.12M1,396.13M1,480.99M1,433.58M
Invested CapitalInvested Cap.
903.41M868.94M857.67M816.56M735.78M751.77M774.21M825.24M787.84M992.13M927.19M862.29M799.72M741.95M1,134.68M1,057.21M973.69M1,248.77M1,272.53M1,179.87M
Asset Utilization RatioAsset Util.
0.000.040.040.050.070.050.060.060.060.270.260.270.290.060.050.040.040.100.110.11
Leverage & Solvency
Debt Ratio
0.040.030.020.010.020.010.010.010.010.010.010.010.010.010.000.000.010.010.070.08
Valuation
Price to EarningsP/E
-209.60-84.23-57.75-37.83-30.63-72.69-23.63-30.07-19.8715.56-27.55-21.20-20.92-22.96-18.13-16.78-21.8211.55-25.96-28.89
Price to SalesP/S
0.01M106.72474.01163.45212.46139.1394.15123.74111.047.03366.88163.97141.7568.98262.90202.45253.6624.7277.140.01M
Price to BookP/B
6.906.594.823.404.703.802.993.072.452.262.982.262.562.831.741.632.552.282.103.32
Enterprise Value
4,960.17M4,889.96M3,700.03M2,456.16M3,200.09M1,709.52M1,219.74M1,416.04M893.68M1,032.16M1,624.00M922.14M1,096.94M1,223.36M743.93M563.57M1,385.03M1,575.27M1,236.69M2,391.12M
EV to EBIT
-71.23-77.03-48.54-29.97-35.05-19.21-12.33-13.86-8.257.77-15.60-8.79-10.30-12.23-6.24-4.69-10.92-90.30-11.53-18.89
EV to EBITDA
-71.23-77.03-48.54-29.97-35.05-19.21-12.33-13.86-8.257.77-15.60-8.79-10.30-12.23-6.24-4.69-10.92-90.30-11.53-18.89
Market Capitalization
5,893.58M5,449.95M3,996.85M2,721.78M3,356.60M2,787.66M2,279.21M2,489.06M1,909.14M2,222.04M2,718.56M1,930.31M2,022.69M2,074.10M1,963.88M1,713.91M2,460.00M2,820.48M2,448.34M3,544.04M
Price to FCFP/FCF
-0.00M-472.3119.67-41.32-38.90-35.99-18.92-25.88-19.5316.90-26.60-22.72-22.55-26.14-18.36-21.54-28.44-32.41-18.73-51.73
EV to FCF
-0.00M-423.7818.21-37.29-37.09-22.07-10.12-14.72-9.147.85-15.89-10.85-12.23-15.42-6.96-7.08-16.01-18.10-9.46-34.90
EV to CFO
0.00M0.00M16.93-46.98-42.96-24.71-11.11-16.72-9.957.64-16.28-11.11-12.45-16.02-7.16-7.37-17.00-18.91-9.62-36.18
Return Ratios
Return on Sales [ROS]ROS
-9,126.34%-124.31%-904.00%-492.23%-577.90%-444.10%-408.66%-507.79%-629.72%42.02%-1,405.29%-891.06%-746.40%-332.71%-1,596.87%-1,419.22%-1,307.60%-15.29%-337.81%-25,827.14%
Return on Capital Employed [ROCE]ROCE
-40.04%-35.61%-21.55%-23.81%-27.32%-30.16%-32.33%-33.64%-36.15%-15.09%-14.86%-16.28%-17.40%-43.49%-37.66%-35.54%-39.90%-29.53%-26.42%-27.95%
Return on Invested Capital [ROIC]ROIC
-46.07%-48.25%-49.94%-20.21%-19.14%-20.83%-22.22%-53.92%-45.91%-27.29%
Return on Assets [ROA]ROA
-32.04%-26.78%-15.54%-17.29%-21.98%-20.65%-21.79%-21.90%-23.16%-9.10%-9.11%-10.43%-11.28%-32.56%-30.15%-27.90%-30.70%-4.54%-3.46%-4.75%